Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial, The Lancet

Study (n=14 892 [66%] of 22,560 in RECOVERY trial) found aspirin was not linked to reductions in 28 day mortality or in risk of progressing to invasive mechanical ventilation or death, but was associated with a small increase in rate of being discharged alive within 28 days.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news